Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-08-12 00:00:00 ET · period of report 2022-08-10 · accession 0001493152-22-022415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-12 | 2022-08-10+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +14.1K | 1,347 | New | +$24.5K |
| DM | 2022-08-12 | 2022-08-10+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $24.07 | -14.1K | 780 | -95% | -$338.6K |
| DM | 2022-08-12 | 2022-08-10+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $0.00 | -14.1K | 18.6K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | M | A | 12,720 | $1.74 | 12,720 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-11 | S | D | 79 | $24.55 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-11 | S | D | 1,268 | $23.89 | 79 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.47 to $24.26, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-08-11 | M | A | 1,347 | $1.74 | 1,347 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-10 | S | D | 780 | $24.48 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.435 to $25.15, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2022-08-10 | S | D | 11,940 | $24.06 | 780 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.43 to $24.40, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-08-10 | M | D | 12,720 | $0.00 | 19,930 | D | $1.74 · — to 2030-09-03 | 12,720 Common Stock | (F5) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-08-11 | M | D | 1,347 | $0.00 | 18,583 | D | $1.74 · — to 2030-09-03 | 1,347 Common Stock | (F5) A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. |